Meiogenix and Lesaffre enter into a collaboration agreement to develop improved industrial yeast strains using Meiogenix’s recombination technologies. The PhoeniX technology developed by Meiogenix controls the process of natural meiotic recombination and generates efficiently non–GM recombined yeast cells particularly for industrial strains where meiosis is impeded.

Download the press release